Genomic amplicons target vesicle recycling in breast cancer
- PMID: 19620778
- PMCID: PMC2719927
- DOI: 10.1172/JCI40256
Genomic amplicons target vesicle recycling in breast cancer
Abstract
Aberrant endocytosis, vesicle targeting, and receptor recycling represent emerging hallmarks of cancer. In this issue of the JCI, Zhang and colleagues demonstrate that RAB-coupling protein (RCP; also known as RAB11FIP1) is a "driver" of the 8p11-12 amplicon in human breast cancer and mouse xenograft models of mammary carcinogenesis (see the related article beginning on page 2171). Their finding that RAB GTPase function enables genomic amplification to confer aggressiveness to mammary tumors adds significantly to the body of evidence supporting pivotal roles for receptor trafficking in the proliferation and metastasis of cancer.
Figures


Comment on
-
RCP is a human breast cancer-promoting gene with Ras-activating function.J Clin Invest. 2009 Aug;119(8):2171-83. doi: 10.1172/JCI37622. Epub 2009 Jul 20. J Clin Invest. 2009. PMID: 19620787 Free PMC article.
References
-
- Kauraniemi P., Barlund M., Monni O., Kallioniemi A. New amplified and highly expressed genes discovered in the ERBB2 amplicon in breast cancer by cDNA microarrays. Cancer Res. 2001;61:8235–8240. - PubMed